Suppr超能文献

基因工程改造的加里德明和表皮素类似物的分离与特性分析。

Isolation and characterization of genetically engineered gallidermin and epidermin analogs.

作者信息

Ottenwälder B, Kupke T, Brecht S, Gnau V, Metzger J, Jung G, Götz F

机构信息

Mikrobielle Genetik, Universität Tübingen, Germany.

出版信息

Appl Environ Microbiol. 1995 Nov;61(11):3894-903. doi: 10.1128/aem.61.11.3894-3903.1995.

Abstract

Gallidermin (Gdm) and epidermin (Epi) are highly homologous tetracyclic polypeptide antibiotics that are ribosomally synthesized by a Staphylococcus gallinarum strain and a Staphylococcus epidermidis strain, respectively. These antibiotics are secreted into media and are distinguished by the presence of the unusual amino acids lanthionine, 3-methyllanthionine, didehydrobutyrine, and S-(2-aminovinyl)-D-cysteine, which are formed by posttranslational modification. To study the substrate specificities of the modifying enzymes and to obtain variants that exhibit altered or new biological activities, we changed certain amino acids by performing site-specific mutagenesis with the Gdm and Epi structural genes (gdmA and epiA, respectively). S. epidermidis Tü3298/EMS6, an epiA mutant of the Epi-producing strain, was used as the expression host. This mutant synthesized Epi, Gdm, or analogs of these antibiotics when the appropriate genes were introduced on a plasmid. No Epi or Gdm analogs were isolated from the supernatant when (i) hydroxyamino acids involved in thioether amino acid formation were replaced by nonhydroxyamino acids (S3N and S19A); (ii) C residues involved in thioether bridging were deleted (delta C21, C22 and delta C22); or (iii) a ring amino acid was replaced by an amino acid having a completely different character (G10E and Y20G). A strong decrease in production was observed when S residues involved in thioether amino acid formation were replaced by T residues (S16T and S19T). A number of conservative changes at positions 6, 12, and 14 on the Gdm backbone were tolerated and led to analogs that had altered biological properties, such as enhanced antimicrobial activity (L6V) or a remarkable resistance to proteolytic degradation (A12L and Dhb14P). The T14S substitution led to simultaneous production of two Gdm species formed by incomplete posttranslational modification (dehydration) of the S-14 residue. The fully modified Dhb14Dha analog exhibited antimicrobial activity similar to that of Gdm, whereas the Dhb14S analog was less active. Both peptides were more sensitive to tryptic cleavage than Gdm was.

摘要

加里德明(Gdm)和表皮菌素(Epi)是高度同源的四环多肽抗生素,分别由鸡葡萄球菌菌株和表皮葡萄球菌菌株通过核糖体合成。这些抗生素分泌到培养基中,其特征是存在通过翻译后修饰形成的不寻常氨基酸,如羊毛硫氨酸、3-甲基羊毛硫氨酸、双脱氢丁氨酸和S-(2-氨基乙烯基)-D-半胱氨酸。为了研究修饰酶的底物特异性并获得具有改变或新生物活性的变体,我们通过对Gdm和Epi结构基因(分别为gdmA和epiA)进行定点诱变来改变某些氨基酸。表皮葡萄球菌Tü3298/EMS6,即产生Epi菌株的epiA突变体,用作表达宿主。当在质粒上引入适当的基因时,该突变体合成Epi、Gdm或这些抗生素的类似物。当(i)参与硫醚氨基酸形成的羟基氨基酸被非羟基氨基酸取代(S3N和S19A);(ii)参与硫醚桥接的C残基被删除(δC21、C22和δC22);或(iii)环氨基酸被具有完全不同特性的氨基酸取代(G10E和Y20G)时,未从上清液中分离出Epi或Gdm类似物。当参与硫醚氨基酸形成的S残基被T残基取代(S16T和S19T)时,产量显著下降。在Gdm主链的6、12和14位进行了一些保守性改变,这些改变是可以耐受的,并产生了具有改变的生物学特性的类似物,如增强的抗菌活性(L6V)或对蛋白水解降解的显著抗性(A12L和Dhb14P)。T14S取代导致同时产生两种由S-14残基不完全翻译后修饰(脱水)形成的Gdm物种。完全修饰的Dhb14Dha类似物表现出与Gdm相似的抗菌活性,而Dhb14S类似物活性较低。这两种肽比Gdm对胰蛋白酶切割更敏感。

相似文献

1
Isolation and characterization of genetically engineered gallidermin and epidermin analogs.
Appl Environ Microbiol. 1995 Nov;61(11):3894-903. doi: 10.1128/aem.61.11.3894-3903.1995.
2
The biosynthesis of the lantibiotics epidermin, gallidermin, Pep5 and epilancin K7.
Antonie Van Leeuwenhoek. 1996 Feb;69(2):119-127. doi: 10.1007/BF00399417.
3
Engineering of a novel thioether bridge and role of modified residues in the lantibiotic Pep5.
Appl Environ Microbiol. 1996 Feb;62(2):385-92. doi: 10.1128/aem.62.2.385-392.1996.
4
Structural gene isolation and prepeptide sequence of gallidermin, a new lanthionine containing antibiotic.
FEMS Microbiol Lett. 1989 Apr;49(2-3):263-7. doi: 10.1016/0378-1097(89)90050-5.
6
Genetic analysis of epidermin biosynthetic genes and epidermin-negative mutants of Staphylococcus epidermidis.
Eur J Biochem. 1992 Mar 15;204(3):1149-54. doi: 10.1111/j.1432-1033.1992.tb16740.x.
8
Epidermin and gallidermin: Staphylococcal lantibiotics.
Int J Med Microbiol. 2014 Jan;304(1):63-71. doi: 10.1016/j.ijmm.2013.08.012. Epub 2013 Sep 4.

引用本文的文献

1
Modifying the Lantibiotic Mutacin 1140 for Increased Yield, Activity, and Stability.
Appl Environ Microbiol. 2018 Jul 17;84(15). doi: 10.1128/AEM.00830-18. Print 2018 Aug 1.
2
Ribosomal Natural Products, Tailored To Fit.
Acc Chem Res. 2017 Jul 18;50(7):1577-1586. doi: 10.1021/acs.accounts.7b00175. Epub 2017 Jul 6.
3
Carboxyl Analogue of Mutacin 1140, a Scaffold for Lead Antibacterial Discovery.
Appl Environ Microbiol. 2017 Jun 30;83(14). doi: 10.1128/AEM.00668-17. Print 2017 Jul 15.
4
VraH Is the Third Component of the Staphylococcus aureus VraDEH System Involved in Gallidermin and Daptomycin Resistance and Pathogenicity.
Antimicrob Agents Chemother. 2016 Mar 25;60(4):2391-401. doi: 10.1128/AAC.02865-15. Print 2016 Apr.
5
Site-directed mutations in the lanthipeptide mutacin 1140.
Appl Environ Microbiol. 2013 Jul;79(13):4015-23. doi: 10.1128/AEM.00704-13. Epub 2013 Apr 19.
6
Isolation, biochemical characterization, and cloning of a bacteriocin from the poultry-associated Staphylococcus aureus strain CH-91.
Appl Microbiol Biotechnol. 2013 Aug;97(16):7229-39. doi: 10.1007/s00253-012-4578-y. Epub 2012 Nov 30.
7
Activity of gallidermin on Staphylococcus aureus and Staphylococcus epidermidis biofilms.
Antimicrob Agents Chemother. 2012 Nov;56(11):5804-10. doi: 10.1128/AAC.01296-12. Epub 2012 Aug 27.
8
Bioengineering: a bacteriocin perspective.
Bioengineered. 2012 Nov-Dec;3(6):313-9. doi: 10.4161/bioe.21601. Epub 2012 Aug 24.
10
Synthesis of trypsin-resistant variants of the Listeria-active bacteriocin salivaricin P.
Appl Environ Microbiol. 2010 Aug;76(16):5356-62. doi: 10.1128/AEM.00523-10. Epub 2010 Jun 25.

本文引用的文献

1
Lantibiotics--unusually modified bacteriocin-like peptides from gram-positive bacteria.
Zentralbl Bakteriol. 1993 Feb;278(1):1-22. doi: 10.1016/s0934-8840(11)80275-6.
3
Regulation of epidermin biosynthetic genes by EpiQ.
Mol Microbiol. 1993 Jul;9(1):31-9. doi: 10.1111/j.1365-2958.1993.tb01666.x.
4
The mode of action of SA-FF22, a lantibiotic isolated from Streptococcus pyogenes strain FF22.
Eur J Biochem. 1994 Jan 15;219(1-2):699-705. doi: 10.1111/j.1432-1033.1994.tb19986.x.
8
Construction of an expression system for engineering of the lantibiotic Pep5.
Appl Environ Microbiol. 1994 Dec;60(12):4332-8. doi: 10.1128/aem.60.12.4332-4338.1994.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验